Decreased CSF acetylcholinesterase activity in Alzheimer's disease.

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.

Bibliographic Details
Main Authors:	Appleyard, M, Smith, A, Wilcock, G, Esiri, M
Format:	Journal article
Language:	English
Published:	1983

Similar Items

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.
Published: (2013-01-01)

Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
by: Appleyard, M, et al.
Published: (1987)

Age and Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1983)

The olfactory bulbs in Alzheimer's disease.
by: Esiri, M, et al.
Published: (1984)

Asymmetry of pathology in Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1987)

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
by: Yi Li, et al.
Published: (2022-03-01)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
by: Wilcock, G, et al.
Published: (1982)

Alzheimer disease and acetylcholinesterase inhibitors
by: Zahia Kabouche
Published: (2016-12-01)

The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
by: Wilcock, G, et al.
Published: (1983)

Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson’s Disease
by: Kyu Hwan Shim, et al.
Published: (2021-05-01)

Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.
by: Chapel, H, et al.
Published: (1984)

Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus
by: Aleksi Vanninen, et al.
Published: (2021-03-01)

Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors
by: Alžběta Kračmarová, et al.
Published: (2015-08-01)

Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease
by: Kyu Hwan Shim, et al.
Published: (2021-07-01)

Pathologic diagnosis of Alzheimer's.
by: Köster, R, et al.
Published: (1989)

N-acetylcholinesterase-induced apoptosis in Alzheimer's disease.
by: Debra Toiber, et al.
Published: (2008-09-01)

SOME OBSERVATIONS ON THE DISTRIBUTION OF CORTICAL TANGLES IN ALZHEIMERS-DISEASE
by: Esiri, M, et al.
Published: (1985)

Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease
by: François-Xavier Toublet, et al.
Published: (2019-07-01)

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
by: Palmer, A, et al.
Published: (1987)

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1983)

Prediction of anti-alzheimer's activity of flavonoids targeting acetylcholinesterase in silico
by: Das, S., et al.
Published: (2017)

Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.
by: Pearson, R, et al.
Published: (1985)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
by: Miners, J, et al.
Published: (2006)

Non-immunoglobin in cerebrospinal fluid of patients with Alzheimer's disease and cerebral amyloid angiopathy.
by: Esiri, M, et al.
Published: (1985)

Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
by: Jean, L, et al.
Published: (2007)

Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease
by: Jean, L, et al.
Published: (2007)

Chemokines in CSF of Alzheimer's disease patients
by: Jôice Dias Corrêa, et al.
Published: (2011-06-01)

The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
by: Immacolata Vecchio, et al.
Published: (2021-07-01)

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
by: Ruocheng Dong, et al.
Published: (2021-01-01)

Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
by: Pearce, B, et al.
Published: (1984)

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
by: Óscar M. Bautista-Aguilera, et al.
Published: (2020-05-01)

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease
by: Paroni G, et al.
Published: (2014-10-01)

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy
by: Ashwani Arya, et al.
Published: (2021-02-01)

Altered levels of acetylcholinesterase in Alzheimer plasma.
by: María-Salud García-Ayllón, et al.
Published: (2010-01-01)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
by: Delvenne, A, et al.
Published: (2024)

Study of neuroprotective activity of new acetylcholinesterase inhibitors TVA and TVS in experimental model of Alzheimer’s disease
by: Hrachik V. Gasparyan, et al.
Published: (2022-11-01)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
by: Ruocheng Dong, et al.
Published: (2023-08-01)

Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer’s Disease Drug Determination
by: Alexey Ivanov, et al.
Published: (2024-02-01)

Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?
by: Irina V. Zueva, et al.
Published: (2023-11-01)

Advances on plant extracts and phytocompounds with acetylcholinesterase inhibition activity for possible treatment of Alzheimer's disease
by: Rashid Taqui, et al.
Published: (2022-02-01)